Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Coivas vs WellMedRx

Coivas
Graded #194

Higher grade

vs+11.700000000000003
WellMedRx
Graded #456

Lower grade

The verdict

Coivas takes it — 66.2/100 to 54.5/100.

Coivas grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Coivas is an all-inclusive GLP-1 telehealth service operated by WellVi LLC (d/b/a Coivas) with prescriptions through Arora Health & Aesthetics, LLC.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoivas +25
70
45
Dose & formulationCoivas +24
64
40
Clinical oversightCoivas +11
84
73
Labs & monitoringWellMedRx +6
54
60
FulfillmentCoivas +18
78
60
Contract termsWellMedRx +35
20
55
Coivas · left barWellMedRx · right bar

The numbers

MetricCoivasWellMedRx
WeighScore66.2/10054.5/100
GradeCC
Scorecard rank#194#456
Semaglutide$149/mo (quarterly plan, compounded)Not disclosed
Tirzepatide$229/mo (quarterly plan, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Coivas

Graded #194 · C

Strengths

  • All-inclusive pricing: one price covers doctor consult, prescription, shipping and support
  • Compounded semaglutide from $149/mo and tirzepatide from $229/mo on the quarterly plan
  • Names its clinical provider (Arora Health & Aesthetics, LLC) and cites USP 797 / NABP-accredited pharmacies
  • Available in all 50 states; 24/7 support; HSA/FSA eligible; money-back guarantee
  • Most patients approved in under 2 hours; refund if no provider visit or prescription occurs

Where it loses points

  • Dispensing pharmacies described only by category (503A/503B, NABP-accredited) - not named individually
  • Lower quarterly headline price requires a 3-month commitment; monthly plan costs more ($179/$289)
  • Money-back guarantee has strict adherence/verification conditions and no partial/prorated refunds
  • No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only; binding NY arbitration
WellMedRx

Graded #456 · C

Strengths

  • Named licensed pharmacy partner (Mycelium Pharmacy)
  • Clinical care delivered through OpenLoop Health, an established clinician network
  • Multi-product platform — one account covers weight loss, TRT, hair, and sexual health
  • HIPAA-compliant badge on the home page

Where it loses points

  • Monthly pricing not shown until after intake
  • State coverage not disclosed — only 'a licensed professional in your state'
  • No LegitScript registration visible on the home page
  • No NABP .pharmacy seal
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard